title: [European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: CEIPC 2008 Spanish adaptation].
abstract: We present the Spanish adaptation from the CEIPC of the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice 2008. This guide recommends the SCORE model for risk evaluation. The aim is to prevent premature mortality and morbidity due to CVD by means of dealing with its related risk factors in clinical practice. The guide focuses on primary prevention and emphasizes the role of the nurses and primary care medical doctors in promoting a healthy life style, based on increasing physical activity, change dietary habits, and non smoking. The therapeutic goal is to achieve a Blood Pressure <140/90 mmHg, but among patients with diabetes, chronic kidney disease, or definite CVD, the objective is <130/80 mmHg. Serum cholesterol should be <200 mg/dl and cLDL <130 mg/dl, although among patients with CVD or diabetes, the objective is <100 mg/dl (80 mg/dl if feasible in very high-risk patients). Patients with type 2 diabetes and those with metabolic syndrome must lose weight and increase their physical activity, and drugs must be administered whenever applicable, with the objective guided by BMI -body mass index- and waist circumference. In diabetic type 2 patients, the objective is glycated haemoglobin <7%. Allowing people to know the guides and developing implementation programs, identifying barriers and seeking solutions for them, are priorities for the CEIPC in order to put the recommendations into practice.
authors.affiliation: Sociedad Española de Medicina de Familia y Comunitaria. jmlobos@telefonica.net
authors.forename: José M
authors.initials: JM
authors.lastname: Lobos
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Royo-Bordonada
authors.forename: Carlos
authors.initials: C
authors.lastname: Brotons
authors.forename: Luís
authors.initials: L
authors.lastname: Alvarez-Sala
authors.forename: Pedro
authors.initials: P
authors.lastname: Armario
authors.forename: Antonio
authors.initials: A
authors.lastname: Maiques
authors.forename: Dídac
authors.initials: D
authors.lastname: Mauricio
authors.forename: Susana
authors.initials: S
authors.lastname: Sans
authors.forename: Fernando
authors.initials: F
authors.lastname: Villar
authors.forename: Angel
authors.initials: A
authors.lastname: Lizcano
authors.forename: Antonio
authors.initials: A
authors.lastname: Gil-Núñez
authors.forename: Fernando de
authors.initials: Fd
authors.lastname: Alvaro
authors.forename: Pedro
authors.initials: P
authors.lastname: Conthe
authors.forename: Emilio
authors.initials: E
authors.lastname: Luengo
authors.forename: Alfonso Del
authors.initials: AD
authors.lastname: Río
authors.forename: Olga
authors.initials: O
authors.lastname: Cortés-Rico
authors.forename: Ana de
authors.initials: Ad
authors.lastname: Santiago
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Vargas
authors.forename: Mercedes
authors.initials: M
authors.lastname: Martínez
authors.forename: Vicenta
authors.initials: V
authors.lastname: Lizarbe
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood; D004032:Diet; D005060:Europe; D015444:Exercise; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D013030:Spain
chemical_list: D002784:Cholesterol